Intellectus Partners, LLC Amgen Inc Transaction History

Intellectus Partners, LLC

$383 Million
Q3 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $7,094 - $8,621	-27 Reduced 0.65%	4,126 $1.29 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $88,189 - $106,455	328 Added 8.58%	4,153 $1.18 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $1,534 - $1,730	6 Added 0.16%	3,825 $1.1 Million
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $3,061 - $3,800	-14 Reduced 0.37%	3,819 $1.03 Million
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $1,071 - $1,266	5 Added 0.13%	3,833 $851,000
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $43,577 - $53,113	193 Added 5.31%	3,828 $925,000
Q4 2022 Feb 02, 2023	BUY	$229.03 - $291.01 $229 - $291	1 Added 0.03%	3,635 $954,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $8,529 - $9,619	38 Added 1.06%	3,634 $819,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $1,384 - $1,540	6 Added 0.17%	3,596 $875,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $2,411 - $2,668	-11 Reduced 0.31%	3,590 $868,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $17,700 - $20,256	89 Added 2.53%	3,601 $810,000
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $34,600 - $40,538	163 Added 4.87%	3,512 $747,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $7,708 - $8,551	33 Added 1.0%	3,349 $816,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $3,328 - $3,879	15 Added 0.45%	3,316 $825,000
Q4 2020 Feb 18, 2021	BUY	$216.38 - $257.67 $281,510 - $335,228	1,301 Added 65.05%	3,301 $759,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $267,445 - $318,480	-1,236 Reduced 38.2%	2,000 $759,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $3,754 - $4,175	-16 Reduced 0.49%	3,236 $822,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $2,967 - $3,641	-15 Reduced 0.46%	3,252 $767,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $22,962 - $30,454	-126 Reduced 3.71%	3,267 $662,000
Q4 2019 Jan 24, 2020	BUY	$189.21 - $243.2 $567 - $729	3 Added 0.09%	3,393 $818,000
Q3 2019 Oct 11, 2019	BUY	$174.11 - $208.62 $35,170 - $42,141	202 Added 6.34%	3,390 $656,000
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $34,506 - $40,449	207 Added 6.94%	3,188 $587,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $9,043 - $10,194	50 Added 1.71%	2,981 $566,000
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $188,033 - $219,495	-1,054 Reduced 26.45%	2,931 $571,000
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $51,140 - $57,653	-276 Reduced 6.48%	3,985 $826,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $18,099 - $20,329	109 Added 2.63%	4,261 $787,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $67,602 - $79,002	-399 Reduced 8.77%	4,152 $708,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $25,656 - $28,665	152 Added 3.46%	4,551 $791,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $38,142 - $43,548	-228 Reduced 4.93%	4,399 $820,000
Q2 2017 Aug 15, 2017	BUY	N/A	4,627	4,627 $797,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account